Endotoxins are toxic molecules embedded in the outer membrane of certain bacteria. Unlike poisons that bacteria secrete into their surroundings, endotoxins are a structural part of the bacterial cell wall itself, released mainly when the bacteria die and break apart. They are one of the most potent triggers of the human immune system, and even tiny amounts in the bloodstream can cause fever, dangerous drops in blood pressure, and in severe cases, organ failure.
What Endotoxins Are Made Of
Chemically, endotoxins are lipopolysaccharides, often abbreviated LPS. Each molecule has three distinct layers. The outermost layer, called the O-antigen, is a chain of sugars that varies between bacterial species and helps bacteria evade the immune system. The middle layer is a shorter sugar chain known as the core oligosaccharide. The innermost layer, Lipid A, is the part that anchors the molecule into the bacterial membrane and is responsible for nearly all of the toxic effects.
Lipid A is so central to endotoxin toxicity that researchers sometimes use the terms interchangeably. When synthetic Lipid A modeled on E. coli is injected into animals, it produces the same spectrum of effects as a full bacterial infection: fever, inflammation, blood clotting abnormalities, and shock. The sugar chains on the outside matter for how bacteria interact with the immune system, but Lipid A is what makes endotoxins dangerous.
Which Bacteria Produce Endotoxins
Endotoxins come exclusively from Gram-negative bacteria, a broad category defined by the structure of their cell wall. According to the FDA, well-known endotoxin producers include Escherichia coli, Pseudomonas, Klebsiella, Enterobacter, and Proteus. These are common in the environment, in hospitals, and in the human gut. The bacterium responsible for Legionnaires’ disease, Legionella pneumophila, also produces endotoxins, though its toxicity profile differs somewhat from more typical Gram-negative organisms.
Gram-positive bacteria (like Staphylococcus or Streptococcus) do not produce endotoxins. They can produce exotoxins, which are secreted proteins, but their cell walls lack the lipopolysaccharide layer that defines endotoxins.
How Endotoxins Trigger the Immune Response
Your immune system detects endotoxins through a receptor on the surface of immune cells called TLR4 (Toll-like receptor 4). When LPS enters the bloodstream, it binds to a partner molecule called MD-2, and this complex locks onto TLR4. The receptor then pairs up with a second TLR4 molecule, forming a dimer that flips a molecular switch and sends an activation signal into the cell.
Once activated, immune cells (particularly macrophages) begin producing inflammatory signaling molecules, including TNF-alpha and interleukin-1 beta. In a localized infection, this is a proportionate and helpful response. It recruits more immune cells, raises local temperature, and helps contain the bacteria. The problem arises when large quantities of endotoxin flood the bloodstream at once, which typically happens during a severe Gram-negative infection or when antibiotics kill a massive number of bacteria simultaneously.
What Happens During Endotoxin Overload
In controlled studies where healthy volunteers receive a small dose of endotoxin, the physiological changes are striking and rapid. Heart rate climbs, body temperature rises, blood pressure drops, and white blood cell counts spike. The body’s clotting system activates, consuming platelets and reducing levels of natural anticoagulant proteins like protein C. Inflammatory markers such as C-reactive protein and procalcitonin surge to levels comparable to those seen in patients with severe sepsis.
In real-world severe infections, this cascade can spiral out of control. The inflammatory mediators and clotting factors damage the lining of small blood vessels throughout the body, leading to what clinicians call septic shock. Blood pressure drops to dangerous levels, clotting occurs inappropriately inside vessels (disseminated intravascular coagulation), and multiple organs can fail simultaneously. Septic shock from Gram-negative bacteria remains one of the leading causes of death in intensive care units worldwide.
Endotoxins vs. Exotoxins
Endotoxins and exotoxins are fundamentally different in origin, structure, and behavior. Exotoxins are proteins actively secreted by living bacteria, both Gram-negative and Gram-positive. They are highly targeted, often attacking specific cell types or disrupting specific cellular processes. Botulinum toxin, for example, is one of the most lethal substances known, with a potentially fatal dose of just 1 nanogram per kilogram of body weight.
Endotoxins, by contrast, are less potent per molecule but far more heat-stable. While most exotoxins break down at temperatures above 60°C, endotoxins remain stable at 100°C for over an hour. This makes them notoriously difficult to remove from medical equipment and pharmaceutical products through standard sterilization. You can kill the bacteria, but the endotoxin persists. Exotoxins can often be neutralized with specific antitoxins or converted into harmless vaccines (toxoids), while endotoxins cannot.
Testing for Endotoxin Contamination
The standard test for endotoxin contamination uses a substance extracted from the blood cells of horseshoe crabs (the Limulus amebocyte lysate, or LAL test). When LAL encounters endotoxin, it triggers a clotting reaction that can be measured in a lab. The test is extraordinarily sensitive, at least 1,000 times more responsive to endotoxin than to other similar molecules like fungal glucans. Pharmaceutical manufacturers and medical device companies are required to use this test to ensure their products are endotoxin-free before they reach patients.
Metabolic Endotoxemia and Gut Health
You don’t need a raging bacterial infection to be exposed to endotoxins. Trillions of Gram-negative bacteria live in your gut, and under normal conditions, the intestinal lining keeps their endotoxins contained. The barrier works through tight junction proteins that seal the gaps between intestinal cells and a mucus layer that keeps bacteria at a safe distance.
When that barrier breaks down, endotoxins leak into the bloodstream at low but chronically elevated levels, a condition called metabolic endotoxemia. Patients with this condition have circulating LPS levels two to three times higher than normal. High-fat diets and disruptions in the gut bacterial community both contribute to increased intestinal permeability. The leaked endotoxins activate the same TLR4 immune pathway as an acute infection, but at a lower, sustained level, driving chronic low-grade inflammation. This persistent inflammation disrupts insulin signaling, promotes fat accumulation in the liver, and worsens inflammation in fat tissue, linking it to obesity, type 2 diabetes, and metabolic syndrome.
Airborne Endotoxin Exposure
Endotoxins also pose an occupational health risk when inhaled. Workers in agriculture, recycling facilities, wastewater treatment, and animal processing can breathe in dust contaminated with bacterial fragments. No country has established a binding legal limit for airborne endotoxin exposure, but the Dutch Expert Committee on Occupational Safety has recommended a health-based limit of 90 endotoxin units per cubic meter of air for long-term exposure, based on the threshold below which respiratory symptoms don’t appear. Chronic inhalation above this level is associated with airway inflammation, reduced lung function, and occupational asthma.
Neutralizing Endotoxins in Medicine
Treating endotoxin-driven illness is difficult because the damage comes not from the toxin itself but from the body’s own immune overreaction. Antibiotics kill the bacteria but can temporarily worsen the problem by releasing more endotoxin from dying cells. Several approaches have been developed to neutralize circulating endotoxins directly. Polymyxin B, an antibiotic, binds and neutralizes endotoxin effectively but is too toxic to the kidneys and nervous system for routine intravenous use. Instead, it has been incorporated into filter cartridges that clean the blood externally, removing endotoxin without exposing the patient to the drug’s side effects.
Researchers have also explored engineered versions of naturally occurring proteins. Bacterial permeability-increasing protein (BPI), released by activated white blood cells, neutralizes endotoxin as part of the body’s own defense. A synthetic version showed favorable results in clinical trials. Monoclonal antibodies targeting endotoxin have been less successful, largely because the sugar chains on LPS vary so much between bacterial species that a single antibody can’t cover them all.